Physician profile
Nadia Aurora
NPI 1215427778
$293.07
in general payments reported to CMS, 2019-2025
10 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.68 · 2023: $61.78 · 2024: $103 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $47.61 | 2023-2024 | Nexplanon |
| Astellas Pharma US INC | $43.20 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $34.07 | 2024-2025 | Paragard T 380a |
| Glaxosmithkline, LLC. | $31.25 | 2024 | Trelegy Ellipta |
| Exeltis, USA INC. | $30.48 | 2025 | Slynd |
| Janssen Pharmaceuticals, INC | $29.44 | 2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $24.79 | 2025 | |
| Axogen | $19.00 | 2025 | |
| Lilly USA, LLC | $17.55 | 2023 | Mounjaro |
| Alydia Health | $15.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Aurora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.